High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients

Severe acute respiratory syndrome coronavirus 2 is responsible for coronavirus disease 2019 (COVID‐19). While COVID‐19 is often benign, a subset of patients develops severe multilobar pneumonia that can progress to an acute respiratory distress syndrome. There is no cure for severe COVID‐19 and few...

Descripción completa

Detalles Bibliográficos
Autores principales: Archambault, Anne‐Sophie, Zaid, Younes, Rakotoarivelo, Volatiana, Turcotte, Caroline, Doré, Étienne, Dubuc, Isabelle, Martin, Cyril, Flamand, Olivier, Amar, Youssef, Cheikh, Amine, Fares, Hakima, El Hassani, Amine, Tijani, Youssef, Côté, Andréanne, Laviolette, Michel, Boilard, Éric, Flamand, Louis, Flamand, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206770/
https://www.ncbi.nlm.nih.gov/pubmed/34033145
http://dx.doi.org/10.1096/fj.202100540R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206770/
https://www.ncbi.nlm.nih.gov/pubmed/34033145
http://dx.doi.org/10.1096/fj.202100540R

Ejemplares similares